source
- Blackstone bets $1.5B on Pfizer’s obesity drugThe deal will support a sprawling Phase 3 program for a monthly GLP-1 shot Pfizer acquired by winning a bidding war for the drug’s previous owner, Metsera.BioPharma Dive · 4d ago↗ source
- Study warns German drug price hikes could raise US Medicaid spending by $300 millionA new Harvard Medical School study examined the effect of Germany's drug price increases on the United States under President Trump's most‑favored‑nation policy, which ties US federal drug pricing…
- Flagship Pioneering combines Valo Health and Montai Therapeutics into a single company